Epidemological and Molecular Study of patients infected with scabies (Sarcoptes scabiei) in Thiqar Province, Iraq

Authors

  • Dr. Alaa H. Oleiwi Assistant Professor, Department of Biology, College of Science, University of Thiqar, Iraq.
  • Dr Nuha J. Alrikaby Assistant Professor, College of Dentistry, National University of Science and Technology, Thiqar, Iraq
  • Nashaat A. Soud Lecture, College of Dentistry, National University of Science and Technology, Thiqar, Iraq.

DOI:

https://doi.org/10.47750/pnr.2022.13.03.067

Keywords:

Scabies, , Epidemiology, Molecular identification, Thiqar, Iraq

Abstract

The aim of the present study was to epidemiological and molecular detection of patients infected with scabies caused by Sarcoptes scabiei during the period from January2018 to December in the same year in Iraq, Thiqar Province. A total of 721 patients were infected with scabies, 386 (53.5%) were male and 335 (46.5%) were female .Age group 15-45 y old was the most prevalent group (220 patients, 30.5%) infected with scabies. August t 2018 was the highest month in infection (107 patients, 14.8%) and December was the lowest month in infection (20patients, 2.8 %).Students196(27.20%) were the highest percent while the lowest percent of patients were in Crippling 4 (0.6%), However, most such studies have involved epidemological, and limited molecular diagnostic studies. The aim of this study was the genetic characterization of S. scabiei 20 samples from patients ,this study has been the first time in Thi-Qar province . Molecular identification was performed this study in the Laboratory of College of Science, University of Thiqar, using two primers COX and scabie primer . The results showed with agarose gel electrophoresis revealed that 250 bp and 289bp respectively . Visualized under U.V light after staining with Ethidium bromide

Downloads

Published

2022-09-21

Issue

Section

Articles

How to Cite

Epidemological and Molecular Study of patients infected with scabies (Sarcoptes scabiei) in Thiqar Province, Iraq. (2022). Journal of Pharmaceutical Negative Results, 13(3), 437-443. https://doi.org/10.47750/pnr.2022.13.03.067